Chronic myeloid leukemia (CML) is a myeloproliferative disease characterized by Philadelphia (Ph) chromosome and BCR-ABL oncogene (An et al., 2010; Jabbour & Kantarjian, 2020). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.